Page results
-
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
-
This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.
-
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
-
Learn more about the Spectra Optia Funding to Deliver More Apheresis Capacity for Patients
-
Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.
-
UCLH Charity is delighted to announce a generous £1.5 million donation from the Bukhman Philanthropies.
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
Today is International Clinical Trials Day, an important day on the UCLH calendar because research is an integral part of UCLH’s mission.
-
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
File results
-
FOI/2024/0158 - Procedures cancelled due to issues with defective diagnostic equipment
-
FOI/2024/0169 - Medical emergency protocols
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0182 - Women diagnosed with Endometriosis 2019 to 2023
-
FOI/2024/0211 - Acute admissions of women aged 18 to 35 for gynaecology, urology or general surgery 2013-2023
-
FOI/2024/0215 - Agency nursing shifts Band 2 and Band 5 from April 2023 to March 2024
-
FOI/2024/0237 - Staff access to NHS intranet
-
FOI/2024/0238 - Haematology and immunoglobulin treatments
-
FOI/2024/0243 - Pathology laboratory service/ information system at Trust
-
FOI/2024/0255 - Ingenica stock management system in theatres